The present invention relates to a composition for prevention or treatment of obesity or obesity-induced metabolic syndrome containing Enterococcus faecalis as an active ingredient. Specifically, it has been confirmed that Enterococcus faecalis EF-2001 exhibits the effect of inhibiting adipogenesis in adipocytes, and thus the Enterococcus faecalis, a culture solution thereof, or killed bacteria thereof can be greatly usefully used for the prevention, improvement and treatment of obesity that occurs through adipogenesis in adipocytes or obesity-induced metabolic syndrome disease.

A method is disclosed for making palatable methionine-restricted foods, to deliver a methionine-restricted diet to human or veterinary patients. A protein or a food product containing protein is partially oxidized, preferably with ozone, to oxidize nearly all of the methionine and cysteine. After oxidation, tryptophan and lysine are optionally added back since they tend to be oxidized also. Optionally, a small amount of methionine is also added back so that the final methionine is within a preferred range of about 0.85 to about 1.8 gram methionine per 100 gram total protein, preferably about 1.2 gram per 100 gram total protein.

A method is disclosed for making palatable methionine-restricted foods, to deliver a methionine-restricted diet to human or veterinary patients. A protein or a food product containing protein is partially oxidized, preferably with ozone, to oxidize nearly all of the methionine and cysteine. After oxidation, tryptophan and lysine are optionally added back since they tend to be oxidized also. Optionally, a small amount of methionine is also added back so that the final methionine is within a preferred range of about 0.85 to about 1.8 gram methionine per 100 gram total protein, preferably about 1.2 gram per 100 gram total protein.

Provided is a composition for preventing and treating lipid-related metabolic diseases, the composition comprising, as an active ingredient, Lactobacillus plantarum ATG-K2 or Lactobacillus plantarum ATG-K6 isolated from fermented vegetables.

Provided is a composition for preventing and treating lipid-related metabolic diseases, the composition comprising, as an active ingredient, Lactobacillus plantarum ATG-K2 or Lactobacillus plantarum ATG-K6 isolated from fermented vegetables.

The present invention relates to a composition for prevention, alleviation, or treatment of obesity.

The present invention relates to a composition for prevention, alleviation, or treatment of obesity.

Compositions including odd chain saturated fatty acids, and salts and derivatives thereof, and methods for treatment or prophylaxis of conditions related to healthy body weight maintenance are provided, including compositions and methods for supporting a healthy body weight, for satiety/reduced calorie consumption, and/or for efficient fat metabolism.

Compositions including odd chain saturated fatty acids, and salts and derivatives thereof, and methods for treatment or prophylaxis of conditions related to healthy body weight maintenance are provided, including compositions and methods for supporting a healthy body weight, for satiety/reduced calorie consumption, and/or for efficient fat metabolism.

Use of saffron and its active ingredients, such as safranal and/or picrocrocin and/or crocin and/or derivatives thereof, for the production of an active satiation agent for the treatment of problems of overweight.